Navigation Links
Protox Announces Positive Clinical Data from Prostate Cancer Study

ease in PSADT (15 of 15 patients) and a decrease in PSAV (11 of 15 patients), both of which are very positive outcomes for the patient. Results show that in 10 of 15 patients PSA levels were below baseline at 90 days or longer post-treatment. In 14 of the 15 patients, a decrease in PSA levels was observed during at least one of the, 30-, 60- or 90-day follow-up intervals.

The company expects that a final report that will include top-line PSA data with expanded analysis of PSADT and PSAV will be available for release in October. Plans are underway to commence a Phase 2 study before the end of the year.

Conference call

Protox will host a conference call and live webcast today at 12:00 p.m. E.T. to discuss these results. To access the conference call by telephone, dial 416-644-3414 or 1-800-732-9307. Please connect approximately ten minutes prior to the beginning of the call to ensure participation. The conference call will be archived for replay until August 10, 2007 at midnight. To access the archived conference call, dial 416-640-1917 or 1-877-289-8525 and enter the reservation number 21240373 followed by the number sign. A live audio webcast of the conference call will be available at http://www.protoxtherapeutics.com. Please connect at least ten minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. The webcast will be archived at the above website for 30 days.

About Protox

Protox Therapeutics is a leader in advancing novel, targeted protein toxin therapeutics for the treatment of cancer and other proliferative diseases. The company is actively developing two distinct but complementary platforms, INxin(TM) and PORxin(TM), and currently has four programs in clinical
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Protox Announces Publication in Journal of the National Cancer Institute Supporting PRX302 as Treatment for Prostatic Diseases
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:12/22/2014)... 22, 2014 Apnea Sciences ( www.apneasciences.com ) ... Aliso Viejo , California.  Jimmy ... tremendous growth and worldwide expansion, a new facility with ... the anti snore cure have exceeded our expectations and ... are now in 23 countries and will be increasing ...
(Date:12/22/2014)... , Dec. 22, 2014  ConvaTec, a privately-held medical ... has been appointed Interim Chief Executive Officer of the ... succeeds Ken Berger .  "The Board of Directors ... leading ConvaTec over the past three years," said ... Directors.  "We are confident that the company is well ...
(Date:12/22/2014)... 2014  Mark Farrah Associates (MFA), www.markfarrah.com ... of the 2015 marketplace exchange projections and insights ... According to a recent ASPE (Office of ... of Health and Human Services) report, an estimated ... plans through the Marketplace as of October 2014 ...
Breaking Medicine Technology:ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2Insights into the Marketplace and Individual Market Growth 2
... SAN FRANCISCO, June 9 Two long-term, large-scale ... with,type 2 diabetes enrolled more than 9,300 patients ... patient years of,additional experience with AVANDIA. The Veterans ... that based on results from,VADT, there is no ...
... reports this juice has ... with insomnia, NEW YORK, June 9 CherryPharm -- ... health benefits of,cherries -- has been shown to improve aspects ... Medical Center. This double-blind,placebo controlled clinical trial tested the effectiveness ...
Cached Medicine Technology:Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R) 2Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R) 3Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R) 4CherryPharm First All-Natural Food to Improve Sleep 2
(Date:12/25/2014)... Recently, LunaDress.co.uk has updated its blog to provide professional shopping tips ... the models at LunaDress.co.uk come with big discounts, up to 80 ... can turn out to be a most exciting memory and can ... bring surprise to a wedding. On the updated fashion blog, ladies ... for a big day . , Going out with friends to ...
(Date:12/25/2014)... 2014 (HealthDay News) -- The risk of burns from ... you need to be extra cautious, an expert says. ... a significant increase in patients coming in with burns," ... County Volunteer Firefighters Burn Center of Stony Brook University ... full of joy, but if not careful, could quickly ...
(Date:12/25/2014)... 24, 2014 (HealthDay News) -- Among early stage breast ... than half of one percent will eventually develop leukemia ... reveals. The finding comes from a review of ... and 2007, and it suggests that the risk for ... experts had previously thought. "The frequency of bone ...
(Date:12/25/2014)... 25, 2014 AngelWeddingDress.com tries its best ... online realm. Today, the business has introduced its new ... prom dress promotion. , The new prom outfits are ... every dress lover. They are specially designed for 2015. ... dresses should visit its website before Jan. 26, ...
(Date:12/25/2014)... ” was featured on NewsWatch as part of its monthly ... the iOS, Android, and Windows markets. Andrew Tropeano, a mobile ... and shared with viewers how this is an application for ... “A picture says a thousand words.” It’s true. There are ... because each picture holds a unique and special meaning. Photos ...
Breaking Medicine News(10 mins):Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Angelweddingdress 2015 Prom Dresses Online Now 2Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
... ... partnership with New York Downtown Hospital gave a new home to the suddenly displaced, ... , , ... York, NY (Vocus) May 20, 2010 -- BMCC’s Center for Continuing Education and ...
... ... based seminar series targeted at IT professionals , ... (PRWEB) May 20, 2010 -- ITSessions today announced a ... Center on June 17, 2010. This seminar kicks off a new series of technology ...
... ... The cost of healthcare is out of control! Brandi Funk is a ... healthcare and research experience to her quest to aid consumers. “It ... Funk. In her new, informative book, "Cut Your Health Care Costs Now!" ...
... ... students for school wellness recognition. , ... Maitland, FL (Vocus) May 20, 2010 -- Accel Castillo, an eighth-grader from Palm Springs ... 60 competition, beating 198,825 peers from around the country., , , , ,Castillo will be ...
... ... Thome (former Healthcare Market Research Executive) Join The Walden Group, , ... Tarrytown, NY (PRWEB) -- The Walden Group, Inc. ... services for companies in the healthcare industry, is pleased to announce that Daniel J. Doyle ...
... ... , ... May 19, 2010 -- Hit morning show airing on Lifetime Television “The Balancing Act,” and ... search for the Chicken of the Sea SuperCook, someone who can turn simple dishes into ...
Cached Medicine News:Health News:St. Vincent's Hospital Closes—and BMCC Rescues its Paramedic Program 2Health News:ITSessions Announces Desktop Virtualization Seminar 2Health News:ITSessions Announces Desktop Virtualization Seminar 3Health News:New Healthcare Book Helps Families Navigate Rising Healthcare Costs and Decreasing Coverage 2Health News:Palm Springs 8th-Grader Wins National 'Fuel Up To Play 60' Award 2Health News:Palm Springs 8th-Grader Wins National 'Fuel Up To Play 60' Award 3Health News:Palm Springs 8th-Grader Wins National 'Fuel Up To Play 60' Award 4Health News:The Walden Group, a Specialized Strategic Healthcare Investment Banking Firm, Adds Key Advisory Services 2Health News:The Walden Group, a Specialized Strategic Healthcare Investment Banking Firm, Adds Key Advisory Services 3Health News:‘The Balancing Act' and Chicken of the Sea Search for America's ‘Supercook' 2Health News:‘The Balancing Act' and Chicken of the Sea Search for America's ‘Supercook' 3
... Smoothie is deliciously refreshing scrub ... the use of a gentle ... exfoliate the skin to restore ... irritation. This light chemical peel ...
... Acid is derived from sour milk, and is much ... process is very similar to how Glycolic Acid works. ... it is milder than other peels as mentioned above, ... and see the same results as stronger peels. If ...
... System is available in two innovative formulations: ... (70% active). The Level I (40% active) ... willowherb extract, which DCL scientists have identified ... soothe and calm the skin while the ...
... B) Injectable Solution, the only Botulinum Toxin ... in numerous published studies to be safe ... Delivered as a purified, ready-to-use solution, in ... simpler way to significantly reduce abnormal head ...
Medicine Products: